Migraine Research Foundation Grantees

We've funded 72 projects in 12 different countries.

For more grant information, click the researcher's name.

Ahmed, Zubair, Cleveland Clinic, OH

Virtual Method for Assessment and Treatment of Chronic Headache (V-MATCH)

Anderson, Trent, University of Arizona

Neurosteroid Regulation of Cortical Spreading Depression

Andreou, Anna, Kings College London, England

BiTox–a novel, non-paralytic, botulinum toxin A molecule for the treatment of chronic migraine

Andreou, Anna, UCSF, CA

Corticothalamic Feedback and Trigeminothalamic Sensory Processing During Cortical Spreading Depression-Relevance to Migraine with Aura (2010 Heftler Award)

Antal, Andrea and Paulus, Walter, University Medical Center, Georg-August University, Germany

Transcranial Alternating Current Stimulation for the Acute Treatment of Migraine

Ashina, Mossoud, Danish Headache Center, Denmark

Investigation of the serotonergic system in the migraine brain using positron emission tomography

Aylward, Brandon and Powers, Scott, Cincinnati Children's Hospital, OH

The Multidimensional Impact of Migraine in Adolescents Presenting to Specialty Care

Baca, Serapio, Geffen School of Medicine, UCLA, CA

Examining the role of astrocytes in migraine using optogenetic methods

Bates, Emily, Brigham Young University, UT

Finding the Molecular Mechanism of Casein Kinase 1δ Mediated Migraine (2011 Heftler Award)

Berman, Nancy, University of Kansas Medical Center

A Behavioral Model of Menstrual Migraine

Bertisch, Suzanne, Brigham and Women’s Hospital, Boston, MA

Shedding Light on Migraine: Exploring Novel Light Metrics as a Trigger of Migraine (Association of Migraine Disorders Grant)

Borsook, David, Harvard Medical School, MA

Mapping Functional Brain Circuits in a Rodent Model of Central Sensitization

Brennan, K.C., and Kaufmann, Dan, University of Utah

Sex, Stress, and Migraine

Burstein, Rami, Beth Israel Deaconess Medical Center, MA, and Grosberg, Brian, Hartford HealthCare Headache Center, CT

Status migrainosus: differentiating between responders and non-responders in the setup of real-life clinical practice (2016 MRF Impact Award)

Cao, Yu Qing, Washington University Pain Center, MO

Immunotherapy for migraine headache (2013)

The Effects of Calcium Channel Mutations on Trigeminal Ganglion Neurons Innervating the Dura (2009)

Charles, Andrew, Geffen School of Medicine, UCLA, CA

Central Mechanisms of Opioids in the Transformation of Migraine

Cutrer, F. Michael, Mayo Clinic, MN

Whole Exome Sequencing as a Strategy for Gene Discovery in a Large Well Characterized Family with Migraine (2011)

Investigation of the Genetic Basis of Migraine: Building a DNA Library in Migraine Sufferers (2008)

DaSilva, Alexandre, University of Michigan School of Dentistry

Endogenous Opioid Mechanisms in Chronic Migraine

Dussor, Greg and Price, Ted, University of Texas

Afferent stimulation of the trigeminovascular system produces central sensitization via BDNF signaling in the nucleus caudalis

Esposito, Teresa, Institute of Genetics and Biophysics, Italy

The Role of Ionotropic Glutamate Receptor Genes in Migraine

Fernández-Fernández, Jose, Pompeu Fabra University, Spain

Low-throughput evaluation of novel, selective CaV2.1 inhibitors in animal models of Familial Hemiplegic Migraine: modulation of excitatory neurotransmission and analysis of potential therapeutic value (2017)

Identification of novel, selective voltage-gated CaV2.1 calcium channel inhibitors which reverse the gain of channel function produced by Hemiplegic Migraine CACNA1A mutations (2014)

Gelfand, Amy, UCSF, CA

Bringing Relief to Adolescents Naturally with Melatonin (BRAiN-M study)

Geppetti, Pierangelo. University of Florence, Italy

Targeting TRPA1 Channels For Novel Migraine Therapeutics

Ginsburg, Golda, Johns Hopkins School of Medicine, MD

A Pilot Study of Family-Based Cognitive Behavioral Therapy for Treating Chronic Pediatric Headache/Migraine and Comorbid Anxiety

Gold, Michael, University of Pittsburgh, PA

Calcium Activated Chloride Channels as a Novel Target for the Treatment of Migraine

Griffiths, Lyn, Queensland University of Technology, Australia

Use of Next Generation Sequencing Technology to Identify Novel Hemiplegic Migraine and Migraine Related Mutations (Association of Migraine Disorders Grant)

Gudmundsson, Larus, University of Iceland

Psychological Stressors and Their Association with the Life-course of Migraine and its Comorbidity – a Longitudinal Study

Hershey, Andrew, Cincinnati Children’s Hospital, OH

Genomics of Migraine from the CHAMP study: DNA Polymorphism Identification

Kraig, Richard, University of Chicago Medical Center, IL

Preclinical Development of Nasal Insulin as a Therapy for Chronic Migraine (2010)

Microglia and Cytokines Modulate Chronic Migraine (2009)

Lantéri-Minet, Michel, CHU de Nice, France

Intracranial pressure in migraine patients and animal models

LeBel, Alyssa, Boston Children's Hospital, MA

Endogenous Modulation and Central Sensitization in New Daily Persistent Headache (NDPH) in Children

Lipton, Richard, Albert Einstein College of Medicine, NY

Towards a Migraine Genetics Population Laboratory: Building on the American Migraine Prevalence and Prevention Study

May, Arne and Lüdtke, Kerstin. University Medical Center Hamburg-Eppendorf, Germany.

Investigating the effect of high frequency stimulation over the greater occipital nerve onto trigeminal pain perception and Subgrouping migraine patients by manual examination – a potential marker to predict treatment outcomes after greater occipital nerve block?

Nicholson, Robert, Mercy Clinic Headache Center, MO

Assessing adherence to guidelines for the acute treatment of pediatric migraine

Nyholt, Dale and Zhao, Huiying: Queensland University of Technology, Australia

Identifying genetic differences between monozygotic twin pairs discordant for migraine via whole genome sequencing (Werber Family Grant)

Ochs, Jacki and Styron, Susanna, Human Arts Association, NY

Out of My Head, a migraine documentary

Olesen, Jes and Bhatt, Deepak Kumar, Danish Headache Center, Denmark

Developing a pragmatic human model suitable for migraine drug testing combined with the study of biochemical changes during a migraine attack in humans

Oshinsky, Michael, Thomas Jefferson University, PA

Glial Activation and the Chronification of Headache

Polt, Robin and Porreca, Frank, University of Arizona

PACAP antagonists as novel migraine therapies

Porreca, Frank, University of Arizona

Behavioral Model of Medication Overuse Headache

Pozo-Rosich, Patricia: Vall d’Hebron University Hospital, Spain

MicroMIG: searching for new biomarkers in migraine using microRNA expression profile analysis

Ptáček, Louis, UCSF, CA

Generation of mouse models of novel casein kinase 1δ migraine mutations

Recober, Ana. Children’s Hospital of Philadelphia, PA

Oral Microbiome and Inflammation in Pediatric Headache

Renthal, William. Harvard Medical School, MA

Identification of novel migraine therapeutic targets by single cell RNA sequencing of human trigeminal ganglia

Rolan, Paul, School of Medical Sciences, University of Adelaide, Australia

Targeting Glial Inhibition to Attenuate Chronic Migraine: an International Double-blind Randomized, Placebo-controlled Trial of Ibudilast

Romero-Reyes, Marcela, NYU School of Dentistry, NY

The effect of the CGRP receptor antagonist BIBN4096BS on the response to trigeminal nociception, activation and pro-inflammatory cytokine release (2009 Heftler Award)

Scher, Ann, Uniformed Services University, MD

Migraine in Middle Age and Late Life: A Longitudinal Analysis of Factors Related to Migraine Prognosis in a Large Population-Based Cohort

Schürks, Markus and Kurth, Tobias, Brigham and Women’s Hospital, MA

Identification of Genetic Determinants of the Association Between Migraine and Cardiovascular Events: A Genome-Wide Association Study

Schuster, Nathaniel, University of California San Diego Center for Pain Medicine

Efficacy of inhaled cannabis versus placebo for the acute treatment of migraine: a randomized, double-blind, placebo-controlled trial

Shapiro, Robert and Mawe, Gary, University of Vermont

Studies of gastroparesis in monogenic migraine mouse models (Association of Migraine Disorders Grant)

Smitherman, Todd, University of Mississippi

Efficacy of Behavioral Insomnia Treatment for Chronic Migraine: A Randomized Controlled Pilot Study

Stanton, Patric, New York Medical College

N-Methyl-D-Aspartate Receptor Glycine Coagonist Site Modulation as a Potential Treatment for Migraine in Adolescent and Adult Females (2012)

N-Methyl-D-Aspartate Receptor Glycine Coagonist Site Modulation as a Potential Treatment for Migraine (2010)

Starling, Amaal, Mayo Clinic, AZ

Metformin for the Prevention of Episodic Migraine

Wang, Xiaohui, Changchun Institute of Applied Chemistry, China

Phenotypic Identification of Drugs Derived from Traditional Chinese Medicines (TCM) for Treating Migraine Headache

Wessman, Maija & Kallela, Mikko, Folkhälsan Research Center, University of Helsinki

From migraine aura loci to aura genes

Wieseler, Julie and Watkins, Linda, University of Colorado

Why Opioids Enhance Migraine Pain: The Puzzle Points to Glia

Willis, Colin, University of New England, ME

Mechanisms of Blood-brain Barrier Dysfunction Induced Medication Overuse Headache

Yaksh, Tony, UCSD Medical Center, CA

Role of TLR4 and Glial Cells in Histamine and GTN-Induced Migraine Mechanisms

Yarnitsky, David; Granovsky, Yelena; and Granot, Michal, Technion Faculty of Medicine, Israel

Prediction of migraine prevention efficacy: Individualization of treatment by coupling drug's mode of action with patient's mechanism of pain modulation

Yeomans, David. Stanford University School of Medicine, CA

Oxytocin Receptors on Sphenopalatine Ganglia Neurons